Cargando…
Lipid mediator lipoxin A4 and its analog BML-111 exert antitumor effects in melanoma
BACKGROUND: LipoxinA4 (LXA4) is an anti-inflammatory lipid mediator which was recently proposed to have antitumor potential. However, the therapeutic effect of LXA4 in melanoma is still unclear. This work aimed to investigate the function of LXA4 and its analog in melanoma invasion through in vivo a...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246158/ https://www.ncbi.nlm.nih.gov/pubmed/34268415 http://dx.doi.org/10.21037/atm-21-1873 |